Showing results (261-270 of 279) with videos related to
Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2022
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA TrialPhuoc T Tran, Kathryn Lowe, Hua-Ling Tsai, et al.Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate CancerWilliam S Chen, Winston A Haynes, Rebecca Waitz, et al.European Urology|March 21, 2014
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302)Dana E Rathkopf, Matthew R Smith, Johann S de Bono, et al.Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.JAMA Network Open|October 28, 2020
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene AberrationsSabine Schmid, Aurelius Omlin, Celestia Higano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.JAMA Network Open|November 12, 2021
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19Andrew L Schmidt, Matthew D Tucker, Ziad Bakouny, et al.Gynecologic Oncology|April 11, 2026
Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleedingJamie N Bakkum-Gamez, Shariska P Harrington, Seth W Slettedahl, et al.Pageof 28